Latest news
Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist - Business WireBusiness Wire · Tue, 04 Aug 2026 17:44:00 GMTFresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market - Business WireBusiness Wire · Mon, 03 Aug 2026 20:09:00 GMTFresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMT